BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1284768)

  • 1. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C virus and serologic tests for detection of viral hepatitis C].
    Bode JC; Alscher DM
    Med Klin (Munich); 1992 Oct; 87(10):527-31, 549. PubMed ID: 1334216
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C infection in liver transplant patients.
    McCaughan GW; Pau A; Parsons C; McGuinness PH; Gallagher ND; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2256. PubMed ID: 1384207
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of serum hepatitis C virus RNA using the polymerase chain reaction assay].
    Yanagi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1991 Feb; 49(2):292-9. PubMed ID: 1849185
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.
    Roudot-Thoraval F; Pawlotsky JM; Thiers V; Deforges L; Girollet PP; Guillot F; Huraux C; Aumont P; Brechot C; Dhumeaux D
    Hepatology; 1993 May; 17(5):772-7. PubMed ID: 7684017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological diagnosis of hepatitis C virus infection. Role of serological and molecular tests].
    Pawlotsky JM; Lunel F; Zarski JP; Laurent-Puig P; Bréchot C
    Gastroenterol Clin Biol; 1996 Mar; 20(2):146-61. PubMed ID: 8761674
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C.
    Willems M; Moshage H; Fevery J; Yap SH
    Neth J Med; 1992 Aug; 41(1-2):36-43. PubMed ID: 1383840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
    Tullen E; De Saussure P; Soulier-Lauper M
    Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
    Nishiguchi S; Kuroki T; Yabusako T; Seki S; Kobayashi K; Monna T; Otani S; Sakurai M; Shikata T; Yamamoto S
    Hepatology; 1991 Dec; 14(6):985-9. PubMed ID: 1660025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus: the virus responsible of the majority of non A non B hepatitis. First Part: Biology of the virus and clinical and serological aspects of hepatitis C].
    Lunel F
    Gastroenterol Clin Biol; 1992; 16(6-7):518-25. PubMed ID: 1326461
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus.
    Tripathi S; Shetty KJ
    J Assoc Physicians India; 1992 May; 40(5):316-21. PubMed ID: 1282917
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
    Franco A; Muñoz C; Jimenez L; Verdejo F; Arenas D; Olivares J
    Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.